Poly(L-glutamic acid)-paclitaxel conjugate is a potent enhancer of tumor radiocurability

International Journal of Radiation Oncology Biology Physics

Volumn 55, Issue 3, 2003, Pages 707-712

  Milas, Luka ^a   Mason, Kathryn A ^a   Hunter, Nancy ^a   Li, Chun ^a   Wallace, Sidney ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Poly(L glutamic acid) paclitaxel; Radiotherapy; Therapeutic gain; Tumor cure

Indexed keywords

IRRADIATION; ORGANIC POLYMERS; RADIATION; TISSUE;

POLYMERIC CARRIERS;

RADIOTHERAPY;

PACLITAXEL; POLYGLUTAMIC ACID;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RADIOTHERAPY; CONTROLLED STUDY; DRUG CONJUGATION; FEMALE; HAIR; IRRADIATION; JEJUNUM; MOUSE; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL; RADIATION DOSE; SKIN; TISSUE INJURY;

ADENOCARCINOMA; ANIMALS; COMBINED MODALITY THERAPY; CONFIDENCE INTERVALS; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HAIR; INFUSIONS, INTRAVENOUS; JEJUNAL DISEASES; MICE; MICE, INBRED C3H; OVARIAN NEOPLASMS; PACLITAXEL; POLYGLUTAMIC ACID; RADIATION INJURIES; RADIATION-SENSITIZING AGENTS; RADIODERMATITIS; RADIOTHERAPY DOSAGE; SPECIFIC PATHOGEN-FREE ORGANISMS; TAXOIDS;

EID: 0037358299     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)04153-6     Document Type: Article

References (32)

1. Herskovic A., Martz K., Al-Sarraf M., et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med. 326:1992;1593-1598.
2. Brizel D.M., Albers M.E., Fisher S.R., et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med. 338:1998;1798-1804.
3. Morris M., Eifel P.J., Lu J., et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med. 340:1999;1137-1143.
4. Venturini M. Rational development of capecitabine. Eur J Cancer. 38:2001;S3-S9.
5. Miwa M., Ura M., Nishida M., et al. Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue. Eur J Cancer. 34:1998;1274-1281.
6. Gandara D.R., Lara P.N. Jr, Goldberg Z., et al. Tirapazamine Prototype for a novel class of therapeutic agents targeting tumor hypoxia . Semin Oncol. 29:2002;102-109.
7. Mason K.A., Komaki R., Cox J.D., et al. Biology-based combined modality radiotherapy Workshop report . Int J Radiat Oncol Biol Phys. 50:2001;1079-1089.
8. Weiss R.B., Donehower R.C., Wiernik P.H., et al. Hypersensitivity reactions from paclitaxel. J Clin Oncol. 8:1990;1253-1268.
9. Oldham E.A., Li C., Ke S., et al. Comparison of action of paclitaxel and poly(L-glutamic acid)-paclitaxel conjugate in human breast cancer cells. Int J Oncol. 16:1999;125-132.
10. Li C., Newman R.A., Wu Q.-P., et al. Biodistribution of paclitaxel and poly(L-glutamic acid)-paclitaxel conjugates in mice with ovarian OCa-1 tumor. Cancer Chemother Pharmacol. 46:2000;416-422.
11. Maeda H., Seymour L.W., Miyamoto Y. Conjugates of anticancer agents and polymers Advantages of macromolecular therapeutics in vivo . Bioconj Chem. 3:1992;351.
12. Kataoka K. Targetable polymeric drugs. In: Park K, editor. Controlled drug delivery. Washington, DC: American Chemical Society. p. 49-67.
13. Vasey P.A., Kaye S.B., Morrison R., et al. Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxylpropyl)methacrylamide copolymer doxorubicin] First member of a new class of chemotherapeutic agents-drug-polymer conjugates . Clin Cancer Res. 5:1999;83-94.
14. Li C., Yu D.F., Newman R.A., et al. Complete regression of well established tumors using a novel water-soluble poly (L-glutamic acid) paclitaxel conjugate. Cancer Res. 58:1998;2404-2409.
15. Li C., Price J.E., Milas L., et al. Antitumor activity of poly(L-glutamic acid)-paclitaxel on syngeneic and xenografted tumors. Clin Cancer Res. 5:1999;891-897.
16. Milas L., Milas M.M., Mason K.A. Combination of taxanes with radiation Preclinical studies . Semin Radiat Oncol. 9:1999;12-26.
17. Tishler R.B., Geard C.R., Hall E.J., et al. Taxol sensitizes human astrocytoma cells to radiation. Cancer Res. 52:1992;3495-3497.
18. Liebmann J., Cook J.A., Fisher J., et al. In vitro studies of taxol as a potential radiation sensitizer. J Natl Cancer Inst. 6:1994;441-446.
19. Milas L., Hunter N.R., Mason K.A., et al. Role of reoxygenation in induction of enhancement of tumor radioresponse by paclitaxel. Cancer Res. 55:1995;3564-3568.
20. Hall E.J. The oxygen effect. Radiobiology for the radiologist. 2nd ed. 1978;79-92 Harper & Row, Hagerstown, MD.
21. Mason K.A., Kishi K., Hunter N., et al. Effect of docetaxel on the therapeutic ratio of fractionated radiotherapy in vivo. Clin Cancer Res. 5:1999;4191-4198.
22. Li C., Ke S., Wu Q.P., et al. Tumor irradiation enhances the tumor-specific distribution of poly(l-glutamic acid) conjugated paclitaxel and its antitumor efficacy. Clin Cancer Res. 6:2000;2829-2834.
23. Li C., Ke S., Wu Q.P., et al. Potentiation of ovarian OCA-1 tumor radioresponse by poly (L-glutamic acid)-paclitaxel conjugate. Int J Radiat Oncol Biol Phys. 48:2000;1119-1126.
24. Milas L., Hunter N., Mason K., et al. Immunologic resistance to pulmonary metastases in C3Hf/Bu mice bearing syngeneic fibrosarcoma of different sizes. Cancer Res. 34:1974;61-71.
25. Finney D.J. Quantal responses and the tolerance distribution. Statistical methods in biological assay. 1952;454-456 Griffen, London.
26. Withers H.R., Elkind M.M. Microcolony survival assay for cells of mouse intestinal mucosa exposed to radiation. Int J Radiat Oncol Biol Phys. 17:1970;261-267.
27. Masuda K., Matsuura K., Withers H.R., et al. Response of previously irradiated mouse skin to a second course of irradiation Early skin reaction and skin shrinkage . Int J Radiat Oncol Biol Phys. 12:1986;1645-1651.
28. Tannock F., Suit H.D., Marshall N. Vitamin A and the radiation response of experimental tumors An immune-mediated effect . J Natl Cancer Inst. 48:1972;731-741.
29. Milas L., Sito Y., Hunter N.R., et al. Enhanced radioresponse of paclitaxel-sensitive and -resistant tumors in vivo. Eur J Cancer. 33:1997;1299-1308.
30. Milross C.G., Mason K.A., Hunter N.R., et al. Enhanced radioresponse of paclitaxel-sensitive and -resistant tumors in vivo. Eur J Cancer. 33:1997;1299-1308.
31. Griffon-Etienne G., Boucher Y., Brekken C., et al. Taxane-induced apoptosis decompresses blood vessels and lowers interstitial fluid pressure in solid tumors Clinical implications . Cancer Res. 59:1999;3776-3782.
32. Thames H., Ruifrok A.C., Milas L., et al. Accelerated repopulation during fractionated irradiation of a murine ovarian carcinoma Downregulation of apoptosis as a possible mechanism . Int J Radiat Oncol Biol Phys. 35:1996;951-962.